A new press release on newsWire states that Focoline(R) XR has been approved by the FDA in treatment of early morning ADHD symptopms.  This could bring relief to a lot of parents and kids who have traditionally had difficulties in their morning routines.

The press release is copyrighted, so I can’t post it here, but please do follow the link below and see for yourself what the FDA and the Pharmaceuitcal company have to say.

US FDA Approves 30-Minute Onset of Action for Focalin(R) XR, Bringing Potential Benefits to ADHD Patients During Early Morning Period

Popularity: 17% [?]

You Should Also Check Out This Post:

More Active Posts: